Lack of neprilysin suffices to generate murine amyloid‐like deposits in the brain and behavioral deficit in vivo
The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Abstract
Accumulation of the β‐amyloid peptide (Aβ) in the brain is a major pathological hallmark of Alzheimer's disease (AD), leading to synaptic dysfunction, neuronal death, and memory impairment. The levels of neprilysin, a major Aβ‐degrading enzyme, are decreased in AD brains and during aging. Because neprilysin cleaves Aβ in vivo, its down‐regulation may contribute to the pathophysiology of AD. The aim of this study was to assess the consequences of neprilysin deficiency on accumulation of murine Aβ in brains and associated pathologies in vivo by investigating neprilysin‐deficient mice on biochemical, morphological, and behavioral levels. Aged neprilysin‐deficient mice expressed physiological amyloid precursor protein (APP) levels and exhibited elevated brain Aβ concentrations and amyloid‐like deposits in addition to signs of neuronal degeneration in their brains. Behaviorally, neprilysin‐deficient mice acquired a significantly weaker conditioned taste aversion that extinguished faster than the aversion of age‐matched controls. Our data establish that, under physiological APP expression levels, neprilysin deficiency is associated with increased Aβ accumulation in the brain and leads to deposition of amyloid‐like structures in vivo as well as with signs of AD‐like pathology and with behavioral deficits. © 2006 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mucke, L., Masliah, E., Yu, G.-Q., Mallory, M., Rockenstein, E. M., Tatsuno, G., Hu, K., Kholodenko, D., Johnson-Wood, K., & McConlogue, L. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-11-04050.2000 · Cited by 1,856 · cited 4×
“…that the brain concentrations of Journal of Neuroscience Research DOI 10.1002/jnr human Ab are at least 102–103 times higher in those models (Mucke et al., 2000; Kawarabayashi et al., 2001; Leissring et al., 2003) than the murine Ab concentrations found in our aged NEP-deficient mouse…”
BackgroundInfluentialAβ peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease
Janus, C., Pearson, J., McLaurin, J., Mathews, P. M., Jiang, Y., Schmidt, S. D., Chishti, M. A., Horne, P., Heslin, D., French, J., et al. (2000) · Nature · doi:10.1038/35050110 · Cited by 1,431 · cited 1×
“…correlated with the accumulation of Ab in brain and the reduction of Ab content by anti-Ab vaccination caused a reduction of Ab levels and amyloid plaque pathology, leading to an improvement of learning performance of the immunized mice (Chen et al., 2000; Janus et al., 2000; Morgan et al., 2000).”
BackgroundSelf-citationAmyloid, the presenilins and Alzheimer’s disease
Hardy, J. (1997) · Trends in Neurosciences · doi:10.1016/s0166-2236(96)01030-2 · Cited by 1,370 · cited 2×
“Almost all familial forms of AD are characterized by increased deposition of Ab, especially Ab42, resulting in acceleration of AD pathology (Hardy, 1997; Hardy and Selkoe, 2002).”
BackgroundPlaque-independent disruption of neural circuits in Alzheimer’s disease mouse models
Hsia, A. Y., Masliah, E., McConlogue, L., Yu, G.-Q., Tatsuno, G., Hu, K., Kholodenko, D., Malenka, R. C., Nicoll, R. A., & Mucke, L. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.6.3228 · Cited by 1,123 · cited 2×
“In animal models, neuronally expressed Ab42 insufficient to induce plaque formation resulted in deficits in synaptic transmission and synaptotoxicity (Hsia et al., 1999; Mucke et al., 2000) and to age-dependent neuronal loss in hippocampus (Casas et al.”
BackgroundKawarabayashi, T., Younkin, L. H., Saido, T. C., Shoji, M., Ashe, K. H., & Younkin, S. G. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-02-00372.2001 · Cited by 1,053 · cited 1×
“…that the brain concentrations of Journal of Neuroscience Research DOI 10.1002/jnr human Ab are at least 102–103 times higher in those models (Mucke et al., 2000; Kawarabayashi et al., 2001; Leissring et al., 2003) than the murine Ab concentrations found in our aged NEP-deficient mouse brains.”
BackgroundInfluentialIntraneuronal Aβ42 Accumulation in Human Brain
Gouras, G. K., Tsai, J., Naslund, J., Vincent, B., Edgar, M., Checler, F., Greenfield, J. P., Haroutunian, V., Buxbaum, J. D., Xu, H., et al. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64700-1 · Cited by 991 · cited 1×
“…well known that Ab production and the intraneuronal accumulation of Ab precede plaque formation in AD brains as well as in a transgenic mouse model of AD (Gouras et al., 2000; Wirths et al., 2001; Mohajeri et al., 2004), suggesting that sole accumulation of Ab in brains impairs neuronal function.”
BackgroundIwata, N., Tsubuki, S., Takaki, Y., Watanabe, K., Sekiguchi, M., Hosoki, E., Kawashima-Morishima, M., Lee, H.-J., Hama, E., Sekine-Aizawa, Y., et al. (2000) · Nature Medicine · doi:10.1038/72237 · Cited by 867
A learning deficit related to age and β-amyloid plaques in a mouse model of Alzheimer's disease
Chen, G., Chen, K. S., Knox, J., Inglis, J., Bernard, A., Martin, S. J., Justice, A., McConlogue, L., Games, D., Freedman, S. B., et al. (2000) · Nature · doi:10.1038/35050103 · Cited by 740
Casas, C., Sergeant, N., Itier, J.-M., Blanchard, V., Wirths, O., van der Kolk, N., Vingtdeux, V., van de Steeg, E., Ret, G., Canton, T., et al. (2004) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63388-3 · Cited by 400
Wirths, O., Multhaup, G., Czech, C., Blanchard, V., Moussaoui, S., Tremp, G., Pradier, L., Beyreuther, K., & Bayer, T. A. (2001) · Neuroscience Letters · doi:10.1016/s0304-3940(01)01876-6 · Cited by 336
Age- and region-dependent alterations in Aβ-degrading enzymes: implications for Aβ-induced disorders
Caccamo, A., Oddo, S., Sugarman, M. C., Akbari, Y., & LaFerla, F. M. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2004.06.013 · Cited by 299 · cited 4×
“…Ab deposition in the brain (Iwata et al., 2001) and with reports describing the selective reduction of NEP expression in brains with sporadic AD, particularly in high-plaque regions, such as hippocampus and temporal gyrus (Yasojima et al., 2001a,b), and during normal aging (Caccamo et al., 2005).”
InfluentialSchmitz, C., Rutten, B. P. F., Pielen, A., Schäfer, S., Wirths, O., Tremp, G., Czech, C., Blanchard, V., Multhaup, G., Rezaie, P., et al. (2004) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63235-x · Cited by 281 · cited 3×
“Similarly, accumulation of Ab in brains of transgenic mice expressing AD-related APP and presenilin mutations leads to massive neuronal loss in the hippocampus (Casas et al., 2004; Dickson, 2004; Schmitz et al., 2004), reconfirming that high Ab levels are toxic to neurons in vivo.”
BackgroundFukami, S., Watanabe, K., Iwata, N., Haraoka, J., Lu, B., Gerard, N. P., Gerard, C., Fraser, P., Westaway, D., George-Hyslop, P. S., et al. (2002) · Neuroscience Research · doi:10.1016/s0168-0102(02)00015-9 · Cited by 157 · cited 2×
“The reasons for regional differences in the Ab pathology may include the presence of apolipoprotein E or regional differences in the ability to metabolize Ab (Fukami et al., 2002).”
Self-citationApelt, J., Ach, K., & Schliebs, R. (2003) · Neuroscience Letters · doi:10.1016/s0304-3940(03)00030-2 · Cited by 140
Impaired conditioned taste aversion learning in APP transgenic mice
Janus, C., Welzl, H., Hanna, A., Lovasic, L., Lane, N., St. George-Hyslop, P., & Westaway, D. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2003.11.007 · Cited by 51 · cited 5×
“Mice were subjected to forced extinction at days 34 and 42 by offering them only saccharine for 2 hr (Welzl et al., 2001; Janus et al., 2004) and the two-bottle choice test was then performed at days 35, 43, and 44.”
MethodResultSelf-citation
Cited by
Alzheimer disease models and human neuropathology: similarities and differences
Duyckaerts, C., Potier, M.-C., & Delatour, B. (2008) · Acta Neuropathologica · doi:10.1007/s00401-007-0312-8 · Cited by 375
Aβ-degrading enzymes: potential for treatment of Alzheimer disease
Miners, J. S., Barua, N., Kehoe, P. G., Gill, S., & Love, S. (2011) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3182345e46 · Cited by 265
“Inactivation of NEP in hAPP mice not only increased AA, including oligomeric AA (82), causing plaque-like deposits in the brain, but also impaired synaptic plasticity, caused behavioral and cognitive abnormalities (82, 151) and CAA (152).”
BackgroundMechanisms of Amyloid-β Peptide Clearance: Potential Therapeutic Targets for Alzheimer's Disease
Yoon, S.-S., & AhnJo, S.-M. (2012) · Biomolecules and Therapeutics · doi:10.4062/biomolther.2012.20.3.245 · Cited by 205
Accumulation of murine amyloid-β mimics early Alzheimer’s disease
Krohn, M., Bracke, A., Avchalumov, Y., Schumacher, T., Hofrichter, J., Paarmann, K., Fröhlich, C., Lange, C., Brüning, T., von Bohlen und Halbach, O., et al. (2015) · Brain · doi:10.1093/brain/awv137 · Cited by 47
Amyloid β and impairment in multiple memory systems in older transgenic APP TgCRND8 mice
Hanna, A., Horne, P., Yager, D., Eckman, C., Eckman, E., & Janus, C. (2009) · Genes, Brain and Behavior · doi:10.1111/j.1601-183x.2009.00510.x · Cited by 20
Metadata
- Authors
- Madani, R., Poirier, R., Wolfer, D. P., Welzl, H., Groscurth, P., Lipp, H., Lu, B., Mouedden, M. E., Mercken, M., Nitsch, R. M., & Mohajeri, M. H.
- Venue
- Journal of Neuroscience Research
- Publisher
- Wiley
- Published
- 2006-09-22
- Volume
- 84
- Issue
- 8
- Pages
- 1871-1878
- ISSN
- 0360-4012 (ISSN-L)
- 1097-4547
- OpenAlex
- W2046861415
- Cited by
- 86
- References
- 15
- FWCI
- 2.55
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.